Price for Pharmaceutical Goods; Appliances Identifiable for Ostomy Use in the United States - 2023
Contents:
- Price for Pharmaceutical Goods; Appliances Identifiable for Ostomy Use in the United States (CIF) - 2023
- Price for Pharmaceutical Goods; Appliances Identifiable for Ostomy Use in the United States (FOB) - 2023
- Imports of Pharmaceutical Goods; Appliances Identifiable for Ostomy Use in the United States
- Exports of Pharmaceutical Goods; Appliances Identifiable for Ostomy Use in the United States
Price for Pharmaceutical Goods; Appliances Identifiable for Ostomy Use in the United States (CIF) - 2023
In December 2023, the average import price for pharmaceutical goods; appliances identifiable for ostomy uses amounted to $52,730 per ton, declining by -3% against the previous month. Overall, the import price, however, showed a relatively flat trend pattern. The most prominent rate of growth was recorded in April 2023 when the average import price increased by 103% month-to-month. The import price peaked at $54,354 per ton in November 2023, and then contracted in the following month.
There were significant differences in the average prices amongst the major supplying countries. In December 2023, the country with the highest price was the UK ($101K per ton), while the price for Ireland ($34,232 per ton) was amongst the lowest.
From December 2022 to December 2023, the most notable rate of growth in terms of prices was attained by the UK (+4.7%), while the prices for the other major suppliers experienced more modest paces of growth.
Price for Pharmaceutical Goods; Appliances Identifiable for Ostomy Use in the United States (FOB) - 2023
The average export price for pharmaceutical goods; appliances identifiable for ostomy uses stood at $55,367 per ton in December 2023, picking up by 18% against the previous month. Overall, the export price saw a relatively flat trend pattern. The most prominent rate of growth was recorded in April 2023 an increase of 19% against the previous month. Over the period under review, the average export prices attained the maximum in December 2023.
There were significant differences in the average prices for the major overseas markets. In December 2023, the country with the highest price was Japan ($76,846 per ton), while the average price for exports to Lithuania ($15,633 per ton) was amongst the lowest.
From December 2022 to December 2023, the most notable rate of growth in terms of prices was recorded for supplies to Ireland (+7.5%), while the prices for the other major destinations experienced more modest paces of growth.
Imports of Pharmaceutical Goods; Appliances Identifiable for Ostomy Use in the United States
Imports of pharmaceutical goods; appliances identifiable for ostomy uses into the United States skyrocketed to 4.3K tons in 2022, jumping by 23% on the year before. Over the period under review, total imports indicated a significant expansion from 2019 to 2022: its volume increased at an average annual rate of +22.1% over the last three-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports increased by +82.0% against 2019 indices. The pace of growth appeared the most rapid in 2021 with an increase of 32% against the previous year. Over the period under review, imports of reached the peak figure in 2022 and are likely to continue growth in the immediate term.
In value terms, imports of pharmaceutical goods; appliances identifiable for ostomy uses rose significantly to $167M in 2022. The total import value increased at an average annual rate of +10.0% over the period from 2019 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. The most prominent rate of growth was recorded in 2021 when imports increased by 22% against the previous year. Over the period under review, imports of hit record highs in 2022 and are expected to retain growth in the near future.
| Import of Pharmaceutical Goods; Appliances Identifiable for Ostomy Use in the United States (Million USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| Dominican Republic | 79.9 | 71.0 | 57.1 | 53.7 | -12.4% |
| Hungary | 17.2 | 20.4 | 52.7 | 48.6 | 41.4% |
| Ireland | 5.5 | 7.2 | 13.4 | 16.2 | 43.3% |
| Lithuania | N/A | 1.6 | 8.7 | 12.4 | 178.4% |
| Denmark | 3.0 | 3.2 | 6.7 | 8.0 | 38.7% |
| United Kingdom | 15.2 | 17.9 | 6.4 | 6.2 | -25.8% |
| Costa Rica | 0.3 | 1.1 | 1.0 | 4.7 | 150.2% |
| China | 1.3 | 1.3 | 1.7 | 1.9 | 13.5% |
| Others | 2.9 | 4.8 | 8.9 | 15.0 | 72.9% |
| Total | 125 | 129 | 157 | 167 | 10.1% |
Top Suppliers of Pharmaceutical Goods; Appliances Identifiable for Ostomy Use to the United States in 2022:
- Hungary (1609.0 tons)
- Dominican Republic (1410.0 tons)
- Denmark (313.5 tons)
- Lithuania (202.1 tons)
- Ireland (178.6 tons)
- China (150.7 tons)
- Costa Rica (114.1 tons)
- United Kingdom (67.2 tons)
Exports of Pharmaceutical Goods; Appliances Identifiable for Ostomy Use in the United States
In 2022, approx. 2.4K tons of pharmaceutical goods; appliances identifiable for ostomy uses were exported from the United States; declining by -7.9% on 2021. Overall, exports recorded a mild reduction. The pace of growth appeared the most rapid in 2021 when exports increased by 12% against the previous year. As a result, the exports reached the peak of 2.6K tons, and then reduced in the following year.
In value terms, exports of pharmaceutical goods; appliances identifiable for ostomy uses stood at $124M in 2022. Over the period under review, exports continue to indicate a perceptible curtailment.
| Export of Pharmaceutical Goods; Appliances Identifiable for Ostomy Use in the United States (Million USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| Netherlands | 69.1 | 54.2 | 42.0 | 46.3 | -12.5% |
| Canada | 19.8 | 21.2 | 24.2 | 24.1 | 6.8% |
| Japan | 18.2 | 15.6 | 14.3 | 12.2 | -12.5% |
| Australia | 6.7 | 6.9 | 6.2 | 6.7 | 0.0% |
| Brazil | 4.4 | 4.6 | 4.3 | 6.5 | 13.9% |
| Ireland | 4.5 | 3.5 | 3.5 | 4.2 | -2.3% |
| Mexico | 2.2 | 4.8 | 2.4 | 3.5 | 16.7% |
| Colombia | 0.2 | 0.2 | 0.5 | 2.3 | 125.7% |
| South Korea | 1.7 | 1.8 | 2.0 | 2.2 | 9.0% |
| Lithuania | 0.9 | 1.5 | 2.8 | 1.2 | 10.1% |
| Argentina | 1.1 | 0.8 | 1.7 | 0.9 | -6.5% |
| Others | 11.7 | 9.6 | 12.5 | 13.5 | 4.9% |
| Total | 141 | 125 | 116 | 124 | -4.2% |
Top Export Markets for Pharmaceutical Goods; Appliances Identifiable for Ostomy Use from the United States in 2022:
- Netherlands (676.5 tons)
- Canada (649.4 tons)
- Ireland (179.6 tons)
- Brazil (143.4 tons)
- Japan (143.4 tons)
- Lithuania (116.8 tons)
- Australia (93.4 tons)
- Mexico (65.6 tons)
- Colombia (47.4 tons)
- South Korea (45.7 tons)
- Argentina (27.9 tons)
433
This report provides an in-depth analysis of the blood-grouping reagents market in the U.S..
522
This report provides an in-depth analysis of the chemical contraceptive preparations market in the U.S..
488
This report provides an in-depth analysis of the medical reconstruction cements market in the U.S..
484
This report provides an in-depth analysis of the first-aid kit market in the U.S..
464
This report provides an in-depth analysis of the medical gel preparations market in the U.S..
419
This report provides an in-depth analysis of the x-ray examination preparations market in the U.S..
440
This report provides an in-depth analysis of the market for sterile medical adhesion barrier in the U.S..
579
This report provides an in-depth analysis of the global blood-grouping reagents market.
641
This report provides an in-depth analysis of the global chemical contraceptive preparations market.
694
This report provides an in-depth analysis of the global medical reconstruction cements market.
669
Indian suppliers expand their presence in the American chemical contraceptive market. In January-October 2021, the U.S. imported 1.4K tons of contraceptives from India, 36% more compared to the same period of 2020. Over this period, total U.S. import volume increased by 20%, reaching 2.8K tons. In value terms, purchases rose by 1% to $1.2B. The average contraceptive import price in the U.S. decreased by 16% against the same period in 2020. India remains the primary supplier, with a 44%-share in American imports.
173
Discover the world's leading import markets for chemical contraceptive preparations, including key statistics and numbers. Find out which countries import the most and why.
207
Discover the top import markets for medical gel preparations based on import value data from IndexBox. Learn about the key countries driving the global market for medical gel products.
164
Discover the leading countries for importing X-ray examination preparations and the key statistics behind their market values.
89
Explore the top import markets for sterile medical adhesion barriers around the world. Learn about the key countries driving the demand for these crucial healthcare products.
669
Indian suppliers expand their presence in the American chemical contraceptive market. In January-October 2021, the U.S. imported 1.4K tons of contraceptives from India, 36% more compared to the same period of 2020. Over this period, total U.S. import volume increased by 20%, reaching 2.8K tons. In value terms, purchases rose by 1% to $1.2B. The average contraceptive import price in the U.S. decreased by 16% against the same period in 2020. India remains the primary supplier, with a 44%-share in American imports.
173
Discover the world's leading import markets for chemical contraceptive preparations, including key statistics and numbers. Find out which countries import the most and why.
207
Discover the top import markets for medical gel preparations based on import value data from IndexBox. Learn about the key countries driving the global market for medical gel products.
164
Discover the leading countries for importing X-ray examination preparations and the key statistics behind their market values.
89
Explore the top import markets for sterile medical adhesion barriers around the world. Learn about the key countries driving the demand for these crucial healthcare products.
